| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Hastings Paul J is a Chief Executive Officer at Nkarta, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 26,046 | $2.07 | $53,915.22 | -6.3% | +10.7% | - | |
| Jun 18, 2025 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 1,790 | $1.79 | $3,204.10 | -0.6% | +7.1% | - | |
| Jan 15, 2025 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 17,378 | $2.20 | $38,231.60 | -5.2% | -23.7% | -12.5% | |
| Jun 18, 2024 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 1,770 | $5.60 | $9,912.00 | -0.7% | +7.2% | -65.5% | |
| Jun 13, 2024 | PCRX Pacira Biosciences, Inc. | Director | Sell | 880 | $28.38 | $24,974.40 | -6.5% | -54.2% | -14.6% | |
| Jan 16, 2024 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 9,697 | $8.74 | $84,751.78 | -2.4% | +0.5% | -74.2% | |
| Jun 20, 2023 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 1,704 | $4.85 | $8,264.40 | -0.5% | -67.1% | +8.7% | |
| Jun 5, 2023 | PCRX Pacira Biosciences, Inc. | Director | Sell | 580 | $38.34 | $22,236.62 | -8.1% | -9.8% | -20.8% | |
| May 15, 2023 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 7,000 | $41.85 | $292,950.00 | -49.4% | -13.6% | -27.4% | |
| Jan 17, 2023 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 3,691 | $5.49 | $20,263.59 | -1.2% | -14.2% | +67.2% |